Social Media Ideas for Moderna

<![CDATA[FDA Approves Moderna's mRNA-Based Flu Vaccine ]]>

Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugy...

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines indicatedPhase 1 trial is being conducted in Canada as part of...

Moderna shares double after experimental mRNA cancer treatment passes key test

Moderna annonce le début d'un essai clinique de phase 1 portant sur l’ARNm-1469, son vaccin expérimental contre l'ébolav...

L'essai de phase 1 évaluera l'innocuité et la réponse immunitaire pour une souche de la maladie à virus Ebola pour laquelle aucun vaccin n'est actuellement autoriséL'essai de phase...

U.S. approves Moderna’s mRNA vaccine for flu—the first of its kind

This flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.

MRNA Stock Gets a Shot in the Arm as FDA Approves Moderna Flu Vaccine

Moderna pins hopes on ‘game-changer’ for cancer vaccines

Technology behind blockbuster Covid jabs is yielding promising results in oncology treatment

Moderna (MRNA) Soars 179% as Melanoma Therapy Candidate Rewrites Growth Story

Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test

Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind if approved by re...

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna share...

Moderna’s stock doubles on promising cancer-vaccine results

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

FDA approves Moderna’s mRNA flu vaccine

The clearance paves the way for the first preventive flu shot based on mRNA technology and completes a dramatic regulatory turnaround.

Merck, Moderna Personalized mRNA Cancer Therapy Achieves a First for Melanoma

Merck and Moderna said intismeran autogene, an mRNA cancer vaccine that prompts an immune response to proteins expressed by a patient’s tumors, met the main goal of a pivotal test...

Cancer vaccine treatment that would be the first of its kind passes a key test

Moderna shares shot up after the company announced initial results from a study of an experimental mRNA-based cancer vaccine tailored to individuals.

Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test

Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind if approved by re...

Moderna’s and Merck’s personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage tri...

The shot, paired with Merck's Keytruda, cut the risk of melanoma recurrence in a trial of more than 1,100 patients.

Cancer vaccine treatment that would be the first of its kind passes a key test

Moderna shares shot up after the company announced initial results from a study of an experimental mRNA-based cancer vaccine tailored to individuals.

F.D.A. Approves Moderna’s mRNA Flu Vaccine

The agency had initially refused to even review the application but reversed course after a public outcry.

Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes

Proceeds to be utilized for general corporate purposes which may include the flexibility to invest in the growth of our oncology business and repayment of debtModerna will also pur...

Personalized cancer vaccine shows positive late-stage trial results

Moderna and Merck say an experimental personalized mRNA treatment helped reduce the risk of melanoma returning in a late-stage trial.

Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates

Reports second quarter revenue of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(1.97)Reiterates plan to deliver up to 10% revenue growth in 2026Improves 2026 GAAP...

Moderna reaches "landmark moment" in Melanoma vaccine trial

CBS News medical correspondent Dr. Céline Gounder joins "The Daily Report" to discuss what Moderna's melanoma vaccine breakthrough could mean as clinical trials continue.

Moderna stock surges as melanoma vaccine trial shows "landmark moment"

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.